dihexa safety concerns hgf c-met cancer risk Targeting Alterations in Cancer: A Review of Genetic Drivers and Therapeutic Implications Dihexa (PNB-0408) | c-Met/HGFR Activator
Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress Targeting the HGF c MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis British Journal of Cancer HGF Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment PMC Frontiers HGF and MET: From Brain Development to Neurological Disorders
Pay in 4 interest-free payments of $6.30 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12



